| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/02/1999 | WO1999043854A1 Methods for cleaving single-stranded and double-stranded dna substrates with nucleotide integrase |
| 09/02/1999 | WO1999043853A1 Methods and apparatus for determination of length polymorphisms in dna |
| 09/02/1999 | WO1999043852A1 Diagnostic method and kit for neuropsychiatric diseases using trinucleotide repeats sequence |
| 09/02/1999 | WO1999043851A1 Hla linked pre-eclampsia and miscarriage susceptibility gene |
| 09/02/1999 | WO1999043850A1 Method for the non-specific amplification of nucleic acid |
| 09/02/1999 | WO1999043849A1 Method for identifying highly concentrated nucleic acids |
| 09/02/1999 | WO1999043848A1 Protein interaction and transcription factor trap |
| 09/02/1999 | WO1999043847A1 Method for detection of microbial contamination on food products |
| 09/02/1999 | WO1999043846A1 Method and kit for the detection of explosives |
| 09/02/1999 | WO1999043845A2 Polynucleotide sequencing method and kits therefor |
| 09/02/1999 | WO1999043844A1 Reciprocal subtraction differential display |
| 09/02/1999 | WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | WO1999043832A2 Human proteinase molecules |
| 09/02/1999 | WO1999043831A1 Cprot03, a human cysteine protease |
| 09/02/1999 | WO1999043830A2 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity |
| 09/02/1999 | WO1999043829A2 Cell cycle related proteins |
| 09/02/1999 | WO1999043828A1 Human homolog of the drosophila protein 'fused' |
| 09/02/1999 | WO1999043825A1 Plant flavanone-3-hydroxylase |
| 09/02/1999 | WO1999043816A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 09/02/1999 | WO1999043809A2 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | WO1999043808A1 Human c-maf compositions and methods of use thereof |
| 09/02/1999 | WO1999043807A2 Human channel-related molecules |
| 09/02/1999 | WO1999043806A1 Human smn-like protein |
| 09/02/1999 | WO1999043805A1 Human protein kinase c inhibitor |
| 09/02/1999 | WO1999043798A1 Methods and compositions using tumor specific soluble interleukin-2 receptor alpha molecules |
| 09/02/1999 | WO1999043697A1 Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms |
| 09/02/1999 | WO1999043695A1 Best's macular dystrophy gene |
| 09/02/1999 | WO1999043688A1 Photoactivatable nucleic acid derivatives |
| 09/02/1999 | WO1999043434A1 System and method of aspirating and dispensing reagent |
| 09/02/1999 | WO1999043346A1 Methods for diagnosing and treating autoimmune disease |
| 09/02/1999 | WO1999043345A1 Amino acid degrading enzymes modulate cell death |
| 09/02/1999 | WO1999043311A2 Conjugated suramin or derivatives thereof with peg, polyaspartate or polyglutamate for cancer treatment |
| 09/02/1999 | WO1999043287A2 Phosphate-based dendrimers for bioassays |
| 09/02/1999 | WO1999043208A1 The helios gene |
| 09/02/1999 | WO1999043203A1 Maize plants exhibiting mycorrhizal responsiveness and an enhanced ability to extract phosphorus from soil |
| 09/02/1999 | WO1999043196A2 Method of cancer diagnosis based on the detection of chromosome abnormality |
| 09/02/1999 | WO1999034016A3 A method for identifying and characterizing cells and tissues |
| 09/02/1999 | WO1999034015A3 Polymorphisms within the rsk-3 gene related to cancer and methods of diagnosis, prognosis, and treatment |
| 09/02/1999 | WO1999033958A3 Desaturase |
| 09/02/1999 | WO1999033867A3 Modified nucleic acid analogues |
| 09/02/1999 | WO1999029903A3 Cancer susceptibility mutations of brca1 |
| 09/02/1999 | WO1999028498A3 Method for producing complex dna methylation fingerprints |
| 09/02/1999 | WO1999028485A3 Ribozymes capable of conferring resistance to potyvirus infection, and plants expressing said ribozymes |
| 09/02/1999 | WO1999026724A3 Devices and methods for detecting target molecules in biological samples |
| 09/02/1999 | WO1999023116A9 ASSAY EMPLOYING CadC FUSION PROTEINS |
| 09/02/1999 | WO1999023105A9 Vegi, an inhibitor of angiogenesis and tumor growth |
| 09/02/1999 | WO1999010998A3 Use of shp-1 and shp-2 to detect compounds involved in neuronal survival |
| 09/02/1999 | DE19808534A1 Verfahren zum Nachweis hochkonzentrierter Nukleinsäuren Method for the detection of highly concentrated nucleic acids |
| 09/02/1999 | CA2627799A1 Tumor tissue microarrays for rapid molecular profiling |
| 09/02/1999 | CA2372108A1 Two-dimensional linkage study techniques |
| 09/02/1999 | CA2322206A1 Methods and apparatus for determination of length polymorphisms in dna |
| 09/02/1999 | CA2321986A1 Method of cancer diagnosis based on the detection of chromosome abnormality |
| 09/02/1999 | CA2321963A1 Unique identifier for biological samples |
| 09/02/1999 | CA2321959A1 Methods for diagnosing and treating autoimmune disease |
| 09/02/1999 | CA2321946A1 Methods and compositions using tumor specific soluble interleukin-2 receptor alpha molecules |
| 09/02/1999 | CA2321932A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 09/02/1999 | CA2321870A1 Cell cycle related proteins |
| 09/02/1999 | CA2321869A1 Human proteinase molecules |
| 09/02/1999 | CA2321747A1 Human smn-like protein |
| 09/02/1999 | CA2321746A1 Human protein kinase c inhibitor |
| 09/02/1999 | CA2321667A1 Human channel-related molecules |
| 09/02/1999 | CA2321223A1 Hla linked pre-eclampsia and miscarriage susceptibility gene |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | CA2321142A1 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | CA2321129A1 Best's macular dystrophy gene |
| 09/02/1999 | CA2321098A1 Photoactivatable nucleic acid derivatives |
| 09/02/1999 | CA2320894A1 Protein interaction and transcription factor trap |
| 09/02/1999 | CA2320893A1 Maize plants exhibiting mycorrhizal responsiveness and an enhanced ability to extract phosphorus from soil |
| 09/02/1999 | CA2287878A1 Diagnostic method and kit for neuropsychiatric diseases using trinucleotide repeats sequence |
| 09/02/1999 | CA2287226A1 Human c-maf compositions and methods of use thereof |
| 09/01/1999 | EP0939319A2 Production of spatially defined solid phases for binding assays |
| 09/01/1999 | EP0939136A1 Assay for predicting the angiographic response to lipid-lowering therapy in patients |
| 09/01/1999 | EP0939131A2 Aminopeptidases |
| 09/01/1999 | EP0939130A1 Rna polymerase |
| 09/01/1999 | EP0939128A2 New HCV isolates |
| 09/01/1999 | EP0939124A2 MGBP1 sequences |
| 09/01/1999 | EP0939123A2 Estrogen receptor-related polypetide SBPERR4 |
| 09/01/1999 | EP0939118A1 Method for isolating DNA and RNA from faeces |
| 09/01/1999 | EP0938677A1 Chemiluminescent detection methods using dual enzyme-labeled binding partners |
| 09/01/1999 | EP0938676A1 Combinatorial process for preparing thiazolidinone libraries |
| 09/01/1999 | EP0938589A1 Method of identifying pharmaceuticals from plant extracts |
| 09/01/1999 | EP0938588A2 Signal amplification method |
| 09/01/1999 | EP0938585A1 Detection and quantitation of endotoxin by fluorescence polarization |
| 09/01/1999 | EP0938579A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors |
| 09/01/1999 | EP0938573A2 Plant cellulose synthase and promoter sequences |
| 09/01/1999 | EP0938570A1 MUTANT $g(a)-AMYLASE COMPRISING MODIFICATION AT RESIDUES CORRESPONDING TO A210, H405 AND/OR T412 IN $i(BACILLUS LICHENIFORMIS) |
| 09/01/1999 | EP0938562A2 Pesticidal toxins and nucleotide sequences which encode these toxins |
| 09/01/1999 | EP0938561A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 09/01/1999 | EP0938557A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/01/1999 | EP0938554A1 Human protein kinase c inhibitor homolog |
| 09/01/1999 | EP0938553A1 Dna encoding dp. 75 and a process for its use |
| 09/01/1999 | EP0938548A1 Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof |
| 09/01/1999 | EP0938381A1 Sample collection devices and methods using markers and the use of such markers as controls in sample validation, laboratory evaluation and/or accreditation |
| 09/01/1999 | EP0938320A1 Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
| 09/01/1999 | EP0871767A4 Method for amplifying specific nucleic acid sequences |
| 09/01/1999 | EP0805873B1 Methods for sensitive detection of reverse transcriptase |
| 09/01/1999 | EP0774011B1 Capture assays |
| 09/01/1999 | EP0770143A4 Method to identify tumor suppressor genes |
| 09/01/1999 | EP0765335B1 Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials |
| 09/01/1999 | EP0764218A4 Method of detecting cellular material |